RC Medical is flipping the traditional medical device development script. Instead of starting with an engineer's concept and hunting for a clinical problem, the Lake Forest, California-based venture studio begins in the interventional suite, listening to physicians describe the gaps they encounter weekly. That physician-first approach is the cornerstone of RC Medical's model, according to CEO David Ferrera, who recently outlined how the studio funds, designs, develops, and commercializes products for the interventional radiology market.
"We go to the interventional suite first," Ferrera said. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing."
Rather than taking on contract work for outside clients, RC Medical partners directly with physician-entrepreneurs to identify new technology and new indications for devices, then forms a standalone company to carry each idea forward. This structure ensures that each innovation receives dedicated resources and focus, avoiding the risk of being lost within a larger portfolio.
The studio model is a partnership from the first sketch through commercialization. Physicians contribute deep clinical knowledge, while RC Medical provides engineering, regulatory guidance, and the business discipline needed to bring a product to patients. "A physician knows the problem better than anyone," Ferrera said. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone."
When an idea passes early evaluation, RC Medical doesn't fold it into an existing product line. Instead, it forms a new company with its own team and focus. "Each idea gets its own company, its own team, its own focus," Ferrera said. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." To date, this approach has produced three separate companies: Single Pass, Infinity Neuro, and Sonorous NV, each born from a specific clinical problem described by a physician.
Ferrera brings nearly three decades of experience in interventional neuroradiology and related fields, including roles as co-founder of Blockade Medical and Chief Technology Officer of Balt Global. He emphasizes that physicians in these procedures see problems that never make it into a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he said. "That detail doesn't show up unless you're building with the physician, not for them."
The studio model is designed to catch such details early, before a device design is locked in and difficult to change. This could lead to more effective and safer devices tailored to real-world clinical scenarios, ultimately improving patient care in interventional radiology.
Not every idea is suited for a new company. Ferrera is candid with physicians about whether an idea might be better as a feature of an existing product. "Part of the first conversation is being honest about which one this is," he said. For ideas that do become a newco, the physician's involvement often continues through development and toward market, keeping the clinical need in view at every stage.
For the medical device industry, RC Medical's venture studio model represents a shift toward more collaborative, physician-driven innovation. By aligning engineering and business expertise with frontline clinical insights, the model may accelerate the translation of ideas into viable products, potentially reducing the time and cost of development. For physicians, it offers a structured pathway to bring their insights to life, and for patients, it promises devices that better address the anatomical and procedural challenges they face.
